Ideaya biosciences announces inducement grants under nasdaq listing rule 5635(c)(4)

South san francisco, calif. , april 25, 2025 /prnewswire/ -- ideaya biosciences, inc. (nasdaq: idya), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on april 24, 2025, the compensation committee of ideaya's board of directors granted non-qualified stock options to purchase an aggregate of 185,400 shares of the company's common stock to four newly hired employees.
NDAQ Ratings Summary
NDAQ Quant Ranking